医薬品産業の成長と研究開発機関の立地展開
広島大学大学院文学研究科論集 67 巻
93-110 頁
2007-12 発行
アクセス数 : 1040 件
ダウンロード数 : 174 件
今月のアクセス数 : 1 件
今月のダウンロード数 : 0 件
この文献の参照には次のURLをご利用ください : https://doi.org/10.15027/25594
ファイル情報(添付) |
HiroshimaUnivStudGradSchLett_67_93.pdf
3.4 MB
種類 :
全文
|
タイトル ( jpn ) |
医薬品産業の成長と研究開発機関の立地展開
|
タイトル ( eng ) |
Growth and Location Change of Pharmaceutical Industry in Japan since 1945
|
作成者 | |
収録物名 |
広島大学大学院文学研究科論集
The Hiroshima University studies, Graduate School of Letters
|
巻 | 67 |
開始ページ | 93 |
終了ページ | 110 |
抄録 |
This paper examines growth and location change of pharmaceutical R&D laboratories in Japan since 1945.
The date base was Nationwide List of Research Institutes(Zenkoku Shiken-Kenkyukikan Meikan)published 1963(year1962), 1971-72(1970), 1981-82(1980), 1991-92(1990), and 2002-03(2001). And to understand industrial structure used Japanese Ministry of Health, Labor and Welfare data. The results can be summarized as follows. It is important for pharmaceutical companies that improve R&D to survive global competition. However before 1975, Japanese pharmaceutical companies did not recognize importance of R&D. In 1975, revised patent law was changed this situation. Japanese government has adopted substance patent. So Japanese pharmaceutical companies could not reverse engineering. After that many Japanese companies began to R&D in-house. In 1962 and 1970, R&D laboratories were concentrated in the central Tokyo and Osaka. Because of major pharmaceutical companies' headquarter locate in central Tokyo and Osaka and R&D facilities co-locate with headquarter. In 1980, we could see decentralization of R&D. The number of R&D increased in Toyama, Takaoka, Tokushima and so on. Because of revised patent law in 1975 was effected Japanese companies shift to R&D in-house. In 1990, have an increased number of R&D facilities in Tsukuba Science City where was launched by the national government to encourage the decentralization of R&D from Tokyo. In 1980s, many foreign companies entry into a Japanese market and global R&D competition was very severe. So Japanese pharmaceutical companies would like to build new and large R&D facilities in nearly Tokyo. Environment around the R&D in pharmaceutical industries have been changed and location pattern of R&D facilities also changed. |
著者キーワード |
医薬品産業
研究開発機関
産業構造
集積
日本
|
NDC分類 |
医学 [ 490 ]
|
言語 |
日本語
|
資源タイプ | 紀要論文 |
出版者 |
広島大学大学院文学研究科
|
発行日 | 2007-12 |
出版タイプ | Version of Record(出版社版。早期公開を含む) |
アクセス権 | オープンアクセス |
収録物識別子 |
[ISSN] 1347-7013
[NCID] AA11643449
|